Not Signed In - All Topic Areas
1 - 10 of 20 more >>
News
1 - 2 of 2
- Repeated Radioimmunotherapy With 131I-Labetuzumab In Colorectal Cancer With Liver Metastases Found Safe And Well-Tolerated In Initial Phase II Study
MedicalNewsToday - Sat, 03 Jun 2006 06:00 EST
- ZEVALIN® Radioimmunotherapy May Play Greater Role In Combination With Standard Of Care For Various Types Of Lymphoma
MedicalNewsToday - Tue, 27 Dec 2005 06:00 EST
Clinical Trials
1 - 5 of 61 more >>
- Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma
ClinicalTrials.gov Identifier: NCT00058370 - Recruiting
Adult Medulloblastoma; untreated childhood medulloblastoma
- Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00005592 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
- Phase II Two-Step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma
ClinicalTrials.gov Identifier: NCT00467506 - Recruiting
Thyroid Neoplasms
- Phase 1 Study of Radiosensitization Using Bortezomib in Patients With Relapsed Mantle Cell or Aggressive Lymphoma Receiving Radioimmunotherapy
ClinicalTrials.gov Identifier: NCT00398762 - Recruiting
Lymphoma
- Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma
ClinicalTrials.gov Identifier: NCT00387023 - Recruiting
Non-Hodgkin's Lymphoma; Lymphoma
email this page
print this page
bookmark this page
feedback on this page
